Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot UlcersOrganogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the publication of previously released results from PREPARE1, a prospective, multicenter, randomized controlled trial (RCT) evaluating PuraPly®AM (PCMP) plus standard of care (SoC) compared to SoC alone in hard-to-heal diabetic foot ulcers (DFUs). The trial achieved its primary endpoint, and the results published in the Journal of Wound Care demonstrate statistically significant improvements in wound closure at 12 weeks among patients treated with PuraPly®AM plus SoC, providing clinical evidence supporting the use of PuraPly®AM in one of the most costly and difficult-to-treat chronic wound populations.
- Healthcare Realty Trust IncorporatedHealthcare Realty Trust Releases Eighth Corporate Responsibility ReportHealthcare Realty Trust Incorporated (NYSE: HR) today released its eighth annual Corporate Responsibility Report, highlighting the Company’s 2025 environmental, social, and governance (ESG) initiatives and accomplishments. The report outlines the Company’s progress toward its stated key performance indicators, environmental performance, and disclosures that align with the Task Force on Climate-Related Financial Disclosures (TCFD) and the Sustainability Accounting Standards Board (SASB).
- PROCEPT BioRoboticsPROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
- BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded an inducement grant on October 10, 2026, under BBOT’s 2025 Inducement Plan as a material inducement to the employment of one individual hired by BBOT in September 2026.
- Kaplan Fox & Kilsheimer LLPKaplan Fox Reminds Investors of a Securities Class Action Against Tigo Energy, Inc. (TYGO) - Deadline is November 23, 2026Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tigo Energy, Inc. ("Tigo Energy" or the "Company") (NASDAQ: TYGO) on behalf of investors that purchased or otherwise acquired Tigo Energy securities between February 24, 2026 and August 4, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Tigo Energy and have suffered losses, you may CLICK HERE to contact us. You may also...
- Kaplan Fox Encourages Investors of The Ensign Group, Inc. (NASDAQ: ENSG) Who Suffered Losses to Contact the Firm Before December 7, 2026Kaplan Fox announces a securities class action against The Ensign Group (NASDAQ: ENSG) for investors from Feb. 10, 2022 to June 18, 2026.
- TeraWulf Inc.TeraWulf Schedules Conference Call for Third Quarter 2026 Financial ResultsEarnings Call Set for Friday, November 6, 2026 at 8:00 a.m. ET
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in AppLovin Corporation Lawsuit - APPA securities class action alleges AppLovin management publicly dismissed a "disconnect between market sentiment and the reality of our business" while the pace of meaningful AI model improvement was allegedly already slowing, and APP shareholders who believed that message watched the stock slide
- ASTS DEADLINE: Levi & Korsinsky Reminds AST SpaceMobile, Inc. Investors of Upcoming Securities Class Action DeadlinePromise versus reality: AST SpaceMobile told shareholders a financing had been completed with "minimal dilution," yet the complaint alleges that $3.0 billion of convertible notes followed in nine months and ASTS stock price faltered as a result
- Erie Indemnity CompanyErie Indemnity to host third quarter 2026 pre-recorded conference call and webcastCompanies: Erie Indemnity CompanyErie Indemnity Company (NASDAQ: ERIE) will host a pre-recorded audio webcast with the financial community providing financial results for the third quarter 2026 on Friday, October 30th, at 10 a.m. Eastern Time. Erie Indemnity will issue a press...
- Kaplan Fox & Kilsheimer LLPKaplan Fox & Kilsheimer LLP Notifies Hims & Hers Health, Inc. (HIMS) Investors of a Securities Class Action and a November 2, 2026 Lead Plaintiff DeadlineKaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may also...
- Kaplan Fox & Kilsheimer LLP Alerts Duolingo, Inc. (NASDAQ: DUOL) Investors to a Securities Class Action Deadline on December 7, 2026Kaplan Fox announces a securities class action against Duolingo (NASDAQ: DUOL) for investors from May 2, 2025 to Feb. 26, 2026.